The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 27, 2026 | Reich Kristian | Chief Scientific Officer | Sell(S) | 1K | $20.00 | $22K |
| Jul 22, 2026 | Reich Kristian | Chief Scientific Officer | Sell(S) | 2K | $20.00 | $49K |
| Jul 21, 2026 | Reich Kristian | Chief Scientific Officer | Sell(S) | 50K | $20.02 | $1.0M |
| Jul 20, 2026 | Reich Kristian | Chief Scientific Officer | Sell(S) | 44K | $20.09 | $878K |
| Jul 15, 2026 | Reich Kristian | Chief Scientific Officer | Sell(S) | 16K | $20.01 | $322K |
| Jul 10, 2026 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 68K | $20.02 | $1.4M |
| Jul 9, 2026 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 34K | $20.01 | $679K |
| Jul 1, 2026 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 48K | $20.03 | $957K |
| Jun 22, 2026 | Bodenstedt Matthias | Chief Financial Officer | Sell(S) | 39K | $22.04 | $862K |
| Jun 18, 2026 | Bodenstedt Matthias | Chief Financial Officer | Sell(S) | 3K | $19.60 | $55K |
| Jun 17, 2026 | Reich Kristian | Chief Scientific Officer | Sell(S) | 50K | $19.43 | $972K |
| Jun 17, 2026 | Bodenstedt Matthias | Chief Financial Officer | Sell(S) | 15K | $19.68 | $297K |
| Jun 17, 2026 | Phillips Andrew John | Director | Grant(A) | 22K | — | $0 |
| Jun 17, 2026 | Loy Spike | Director | Grant(A) | 22K | — | $0 |
| Jun 17, 2026 | Moukheibir Catherine | Director | Grant(A) | 22K | — | $0 |
| Jun 17, 2026 | Xavier Ramnik | Director | Grant(A) | 22K | — | $0 |
| Jun 17, 2026 | BVF Partners L P | Director, 10% Owner | Grant(A) | 22K | — | $0 |
| Jun 16, 2026 | Reich Kristian | Chief Scientific Officer | Sell(S) | 50K | $18.70 | $935K |
| Jun 15, 2026 | Reich Kristian | Chief Scientific Officer | Sell(S) | 50K | $18.89 | $945K |
| May 11, 2026 | Bodenstedt Matthias | Chief Financial Officer | Sell(S) | 14K | $20.02 | $273K |
| Apr 14, 2026 | Bodenstedt Matthias | Chief Financial Officer | Sell(S) | 2K | $19.56 | $47K |
| Apr 13, 2026 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 52K | $18.23 | $946K |
| Apr 10, 2026 | Bodenstedt Matthias | Chief Financial Officer | Sell(S) | 2K | $19.51 | $38K |
| Apr 10, 2026 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 98K | $18.41 | $1.8M |
| Apr 9, 2026 | Bodenstedt Matthias | Chief Financial Officer | Sell(S) | 86K | $18.94 | $1.6M |
| Mar 31, 2026 | BVF Partners L P | Director, 10% Owner | Sell(S) | 1.9M | $16.79 | $32.4M |
| Mar 31, 2026 | BVF Partners L P | Director, 10% Owner | Sell(S) | 1.6M | $16.79 | $26.3M |
| Mar 31, 2026 | BVF Partners L P | Director, 10% Owner | Sell(S) | 249K | $16.79 | $4.2M |
| Jan 7, 2026 | Reich Kristian | Chief Scientific Officer | Grant(A) | 520K | — | $0 |
| Jan 7, 2026 | Santos da Silva Jorge | Chief Executive Officer, Director | Grant(A) | 520K | — | $0 |
| Jan 7, 2026 | Bodenstedt Matthias | Chief Financial Officer | Grant(A) | 354K | — | $0 |
| Dec 19, 2025 | Santos da Silva Jorge | Chief Executive Officer, Director | Disposed to issuer(D) | 196K | — | — |
| Dec 19, 2025 | Santos da Silva Jorge | Chief Executive Officer, Director | Conversion(C) | 196K | — | — |
| Dec 19, 2025 | Santos da Silva Jorge | Chief Executive Officer, Director | Conversion(C) | 6K | — | — |
| Dec 19, 2025 | Reich Kristian | Chief Scientific Officer | Disposed to issuer(D) | 35K | — | — |
| Dec 19, 2025 | Reich Kristian | Chief Scientific Officer | Conversion(C) | 35K | — | — |
| Dec 19, 2025 | Reich Kristian | Chief Scientific Officer | Conversion(C) | 1K | — | — |
| Dec 19, 2025 | Bodenstedt Matthias | Chief Financial Officer | Conversion(C) | 294K | — | — |
| Dec 19, 2025 | Bodenstedt Matthias | Chief Financial Officer | Disposed to issuer(D) | 294K | — | — |
| Dec 19, 2025 | Bodenstedt Matthias | Chief Financial Officer | Conversion(C) | 9K | — | — |
| Dec 9, 2025 | Reich Kristian | Chief Scientific Officer | Sell(S) | 73K | $14.43 | $1.1M |
| Dec 9, 2025 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 70K | $14.49 | $1.0M |
| Dec 8, 2025 | Reich Kristian | Chief Scientific Officer | Sell(S) | 130K | $15.08 | $2.0M |
| Dec 8, 2025 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 130K | $15.08 | $2.0M |
| Oct 8, 2025 | Bodenstedt Matthias | Chief Financial Officer | Buy(P) | 11K | $9.09 | $99K |
| Sep 30, 2025 | Cormorant Global Healthcare Master Fund, LP | Insider | Sell(S) | 6K | $6.96 | $41K |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LP | Insider | Sell(S) | 232K | $8.40 | $2.0M |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LP | Insider | Sell(S) | 71K | $9.38 | $664K |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LP | Insider | Sell(S) | 3.4M | $7.58 | $25.7M |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LP | Insider | Sell(S) | 2.8M | $6.61 | $18.5M |
| Sep 2, 2025 | Reich Kristian | Chief Scientific Officer | Disposed to issuer(D) | 49K | — | — |
| Sep 2, 2025 | Reich Kristian | Chief Scientific Officer | Conversion(C) | 49K | — | — |
| Jul 3, 2025 | Moukheibir Catherine | Director | Sell(S) | 24K | $48.79 | $1.1M |
| Jul 3, 2025 | Moukheibir Catherine | Director | Option exercise(M) | 24K | — | $0 |
| Jul 3, 2025 | Moukheibir Catherine | Director | Option exercise(M) | 24K | — | $0 |
| Jun 5, 2025 | BVF Inc | Director, 10% Owner | Grant(A) | 7K | — | $0 |
| Jun 5, 2025 | Phillips Andrew John | Director | Grant(A) | 7K | — | $0 |
| Jun 5, 2025 | Moukheibir Catherine | Director | Grant(A) | 7K | — | $0 |
| Jun 5, 2025 | Xavier Ramnik | Director | Grant(A) | 7K | — | $0 |
| Jun 5, 2025 | Loy Spike | Director | Grant(A) | 7K | — | $0 |
| Jun 5, 2025 | Sturge Simon | Director | Grant(A) | 7K | — | $0 |
| Feb 27, 2025 | Bodenstedt Matthias | Chief Financial Officer | Grant(A) | 96K | — | $0 |
| Feb 27, 2025 | Reich Kristian | Chief Scientific Officer | Grant(A) | 139K | — | $0 |
| Feb 27, 2025 | Santos da Silva Jorge | Chief Executive Officer, Director | Grant(A) | 96K | — | $0 |
| Jan 20, 2025 | Reich Kristian | Chief Scientific Officer | Conversion(C) | 1K | — | — |
| Jan 20, 2025 | Reich Kristian | Chief Scientific Officer | Disposed to issuer(D) | 112K | — | — |
| Jan 20, 2025 | Reich Kristian | Chief Scientific Officer | Conversion(C) | 112K | — | — |
| Jan 20, 2025 | Reich Kristian | Chief Scientific Officer | Conversion(C) | 3K | — | — |
| Oct 4, 2024 | BVF I GP LLC | Director, 10% Owner | Sell(S) | 837K | $50.00 | $41.8M |
| Oct 4, 2024 | BVF I GP LLC | Director, 10% Owner | Sell(S) | 133K | $50.00 | $6.6M |
| Oct 4, 2024 | BVF I GP LLC | Director, 10% Owner | Sell(S) | 1.0M | $50.00 | $51.5M |
| Oct 4, 2024 | Sturge Simon | Director | Sell(S) | 171K | $53.72 | $9.2M |
| Jun 6, 2024 | Biotechnology Value Fund II LP | Director, 10% Owner | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | Loy Spike | Director | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | Sturge Simon | Director | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | Xavier Ramnik | Director | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | Phillips Andrew John | Director | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | Moukheibir Catherine | Director | Grant(A) | 8K | — | $0 |
| Feb 29, 2024 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 5K | $55.89 | $265K |
| Feb 28, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 28K | $55.00 | $1.5M |
| Feb 28, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 32K | $55.00 | $1.8M |
| Feb 28, 2024 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 56K | $55.00 | $3.1M |
| Feb 27, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 29K | $55.00 | $1.6M |
| Feb 27, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 29K | $55.00 | $1.6M |
| Feb 27, 2024 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 63K | $55.00 | $3.5M |
| Feb 21, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 509 | $55.31 | $28K |
| Feb 21, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 569 | $55.30 | $31K |
| Feb 21, 2024 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 1K | $55.27 | $62K |
| Feb 20, 2024 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 20K | $57.44 | $1.1M |
| Feb 20, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 10K | $57.45 | $575K |
| Feb 20, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 10K | $57.43 | $574K |
| Feb 16, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 10K | $60.15 | $602K |
| Feb 16, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 10K | $60.15 | $602K |
| Feb 16, 2024 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 20K | $60.15 | $1.2M |
| Feb 15, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 10K | $60.17 | $602K |
| Feb 15, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 10K | $60.16 | $602K |
| Feb 15, 2024 | Santos da Silva Jorge | Chief Executive Officer, Director | Sell(S) | 20K | $60.18 | $1.2M |
| Feb 14, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 10K | $62.43 | $624K |
| Feb 14, 2024 | Reich Kristian | Chief Scientific Officer | Sell(S) | 10K | $62.42 | $624K |
| Dec 20, 2023 | Bodenstedt Matthias | Chief Financial Officer | Sell(S) | 5K | $58.34 | $307K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-03. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for MLTX